Vienna -based HealthThek scaleup XundWhich has successfully stopped a fund to expand throughout Europe, including strategic focus on the Dutch and UK, in making software as a medical device (SAMD).
The investment round was led by the leadership initiative and joined the J&T Venture, the continued support for existing investors’ Masmutual Ventures, TBA network and Lana Venture, who re -confirmed their promise to the mission and growth of Janand.
Tams PetrovichJande’s co-founder and CEOThe latest investment is the testimony of our team’s hard work in the past years. This will help to accelerate our expansion across Europe when moving forward with our treatment device and Rev, our Cutting-Ez Large Language Model (LLM) solution. We are laid the foundation of a data-powered, personalized healthcare system that re-defines how care is provided today and tomorrowThe “
Lucas Sepper, Tams Petrovics and Joltan Tarab, established in 2018, experts in the development of jaund SAMD, enable digital interaction to diagnose resistance. With the outlook on the most important decisions of healthcare, Janand’s products are already used as insurers, hospitals and pharmaceutical companies as the first digital point of communication.
Today, the company has appointed more than 40 people across its position in Vienna, Budapest and London.
With a growing portfolio of new funds and MDR-assured SAMD Solutions, Homegraown is strengthening its position as European champion in Jand Digital Health Technology.
With the needs of AI-powered medical devices across the continent, Janna believes that they are in a good position for rapid growth. In the upcoming months, the company will accelerate its expansion in the Dutch and the UK, enable digital interaction to determine its MDR-re-technology from preventing it from resisting.
“We are thrilled to be part of a company with Xund, a company that brings clarity to the most important decisions of Healthcare. Their commitment to digitalize the patient’s journey not only enhances the patient’s care but also flows operations for healthcare suppliers. Long expected synthesis of AI technology in patient care is finally happening widely and it is really exciting to bring down the walls between the new technology and inherited healthcare systems.
“We have a lot of confidence in the group and outlook of Xund, and are eager to support their bold expansion efforts to convert healthcare distribution.“Said BalajManage the partner in the Lead Venture.
At the same time, Jand is consolidating its role as a critical infrastructure supplier in Europe’s developed healthcare natural scene – fully combined with the latest investment initiative of EU, which plans to combine 200 billion dollars to invest in AI solution that strengthens technical sovereignty.
David FieldsJ&T has added a partner of Venture: “The future of healthcare is not just digital – it is intelligent, unimportant and deeply integrated. Jande is guided by our investment thesis that AI-powered SAMD solutions will be more efficient, accessible and the basis of data-driven healthcare system.
“What separates Jand is not only its world -class technology and it is not the confidence of some of the largest health services, but its founding party and their bold attitude have also gained the power. Their deep skills, relentless deathThe “
[publish_date
